Your Location：
Home >
Browse articles >
Mechanism of Shugan Huazheng Prescription Against Liver Fibrosis Based on HIF-1α/VEGF/TGF-β1 Pathway
Updated：2024-03-14
Previous|Next

    • Mechanism of Shugan Huazheng Prescription Against Liver Fibrosis Based on HIF-1α/VEGF/TGF-β1 Pathway

    • XING Anli , ZHAO Kunpeng , ZHANG Qiuju , LI Jiena , CHEN Shiyu , GUO Jiaqi , ZHANG Ming
    • Chinese Journal of Experimental Traditional Medical Formulae Vol. 30, Issue 8, Pages: 57-65(2024)

    • DOI： 10.13422/j.cnki.syfjx.20232140     

      CLC：

    Scan QR Code

  •  
  •  

  • AI Introduction

  • Full Text(HTML)

  • Figs( 3 ) Tabs( 5 )

  • References

  • Publication Info

  • Metrics

218

Views

136

Downloads

2

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Effect of Artesunate on Experimental Choroidal Neovascularization and Expression of HIF-1α and VEGF
Modified Taohe Chengqitang Regulates Notch/eNOS Signaling Pathway to Inhibit Hepatic Sinusoidal Capillarization
Danshen Zexie Decoction Ameliorates Metabolic-associated Fatty Liver Disease with Liver Fibrosis by Regulating Glycolysis and Inhibiting NETs
DIA Proteomic Profiling on Staged Regulatory Effect of Tonifying Deficiency and Dredging Collaterals Method on Liver Fibrosis in Rats Based on Theory of "Zhu Ke Jiao"
Pharmacological Review， Challenges， and Future Prospects of Zhusha Anshenwan

Related Author

XING Anli
ZHAO Kunpeng
ZHANG Qiuju
LI Jiena
CHEN Shiyu
GUO Jiaqi
ZHANG Ming
Jia-xian LI

Related Institution

Clinical College， Gansu University of Chinese Medicine
Eye Hospital， China Academy of Chinese Medical Sciences
School of Basic Medical Sciences，Zhejiang Chinese Medical University
The First Affiliated Hospital of Hebei University of Chinese Medicine
College of Traditional Chinese Medicine， Hebei University of Chinese Medicine